End-stage liver disease (cirrhosis) 4
One controversial aspect of microdosing GLP-1s is that, when theyre taken in smaller doses, they often come from compounding pharmacies that make their own versions of FDA-approved drugs
Semaglutide uses a C18 fatty diacid, and tirzepatide uses a C20 fatty diacid structurally similar to retatrutide's approach
And the emergence of GLP-1RA, such as semaglutide, exenatide, and efinopegdutide [116], and so on, can accelerate the drug development of NAFLD which has great therapeutic potential for the treatment of NAFLD [117]
Tip: If you feel sick, eat bland foods like crackers or toast
Speak with your doctor to rule out any hormonal or thyroid-related problems